Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PP6 regulation of Aurora A-TPX2 limits NDC80 phosphorylation and mitotic spindle size. | J Cell Biol | 2023 | 36897279 | PubTator, text mining | PubMed |
| Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. | Eur J Cancer Prev | 2023 | 36896836 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| The role of viruses in cancer development versus cancer therapy: An oncological perspective. | Cancer Med | 2023 | 36880311 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway. | Exp Mol Med | 2023 | 36879115 | PubTator, text mining | PubMed |
| The progress in our understanding of CIN in breast cancer research. | Front Oncol | 2023 | 36874134 | PubTator, text mining | PubMed |
| Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. | Aging (Albany NY) | 2023 | 36863706 | PubTator, text mining | PubMed |
| Bioinformatics analysis based on high-throughput sequencing data to identify hub genes related to different clinical types of COVID-19. | Funct Integr Genomics | 2023 | 36856850 | PubTator, text mining | PubMed |
| Genetic and epigenetic instability induced by betel quid associated chemicals. | Toxicol Rep | 2023 | 36845258 | PubTator, text mining | PubMed |
| Low-Dose Blue Light (420 nm) Reduces Metabolic Activity and Inhibits Proliferation of Human Dermal Fibroblasts. | Life (Basel) | 2023 | 36836688 | PubTator, text mining | PubMed |
| The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. | Int J Mol Sci | 2023 | 36835628 | PubTator, text mining | PubMed |
| Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy. | Int J Mol Sci | 2023 | 36834660 | PubTator, text mining | PubMed |
| c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53. | Cancers (Basel) | 2023 | 36831504 | PubTator, text mining | PubMed |
| Congenital Microcephaly: A Debate on Diagnostic Challenges and Etiological Paradigm of the Shift from Isolated/Non-Syndromic to Syndromic Microcephaly. | Cells | 2023 | 36831309 | PubTator, text mining | PubMed |
| Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. | Biomedicines | 2023 | 36831004 | PubTator, text mining | PubMed |
| Identification of Potential Hub Genes Related to Aflatoxin B1, Liver Fibrosis and Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. | Biology (Basel) | 2023 | 36829489 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. | Biology (Basel) | 2023 | 36829466 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer. | J Transl Med | 2023 | 36829176 | PubTator, text mining | PubMed |
| Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma. | Thorac Cancer | 2023 | 36825773 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=22